Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature

Audio/Video Archives - 2023-2024 Regular Session

Health Finance and Policy

Meetings are listed by date with the most recent meeting at the top. If there is a television recording of the meeting links to that format will be available below.

Back to current committee list

Page: Page Size: 5 Total Results: 57
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12

Health Finance and Policy

2/14/2023
HF1159 (Fischer): Modifying the membership of the Formulary Committee; modifying the procedure for making changes to the preferred drug list.

HF1032 (Bierman): Board of Pharmacy required to provide central repository under contract to administer medication repository program etc.

HF1665 (Bierman): Minnesota's schedules of controlled substances modified. Informational hearing only.

PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows. Written testimony should also be submitted by 5pm the day prior, in Word or PDF format.

Remote or virtual testimony is not available.

To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
Bills Added:
HF1032 (Bierman) - Board of Pharmacy required to provide the central repository under contract to administer medication repository program with any legislative funding provided for the purpose, conforming changes made related to donations of over-the-counter medications, and money appropriated.
HF1159 (Fischer) - Formulary Committee membership modified, procedure modified for making changes to preferred drug list, and related changes made.
HF1665 (Bierman) - Minnesota's schedules of controlled substances modified.
Attachments:

Health Finance and Policy

2/9/2023
HF816 (Hicks): Medical assistance enrollees allowed to opt out of managed care enrollment.

HF239 (Reyer): Hospice respite and end-of-life care medical assistance benefit established for individuals under the age of 22.

HF384 (Reyer): Unrestricted access to services required for diagnosis, monitoring, and treatment of rare diseases.

HF390 (Acomb): No-cost diagnostic services and testing required following mammogram.

PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows, and written testimony is encouraged.

Remote or virtual testimony is not available.

To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
Bills Added:
HF239 (Reyer) - Hospice respite and end-of-life care medical assistance benefit established for individuals under the age of 22.
HF384 (Reyer) - Unrestricted access to services required for diagnosis, monitoring, and treatment of rare diseases.
HF390 (Acomb) - No-cost diagnostic services and testing required following mammogram.
HF816 (Hicks) - Medical assistance enrollees allowed to opt out of managed care enrollment.
Attachments:

Health Finance and Policy

2/7/2023
HF51 (Richardson) - Emmett Louis Till Victims Recovery Program established, and money appropriated.

HF1059 (Richardson) - Grants supporting healthy development of babies during pregnancy and postpartum for families with members who are Black, Indigenous, and People of Color funding provided, and money appropriated.

HF639 (Bahner) - Community solutions for healthy child development grant program established, and money appropriated.

HF712 (Reyer) - Family planning grant funding provided, and money appropriated.

HF1030 (Liebling) - Enrollee cost-sharing eliminated under medical assistance and MinnesotaCare; and individual, small group, and State Employee Group Insurance Program plans prohibited from including cost-sharing.

PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows, and written testimony is encouraged.

To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
Bills Added:
HF51 (Richardson) - Emmett Louis Till Victims Recovery Program established, and money appropriated.
HF1059 (Richardson) - Grants supporting healthy development of babies during pregnancy and postpartum for families with members who are Black, Indigenous, and People of Color funding provided; and money appropriated.
HF639 (Bahner) - Community solutions for healthy child development grant program established, and money appropriated.
HF712 (Reyer) - Family planning grant funding provided, and money appropriated.
HF1030 (Liebling) - Enrollee cost-sharing eliminated under medical assistance and MinnesotaCare; and individual, small group, and State Employee Group Insurance Program plans prohibited from including cost-sharing.
Attachments:

Health Finance and Policy

2/2/2023
Lead overview from MDH Assistant Commissioner Dan Huff.

HF92 (Jordan) - Elevated blood lead concentration level lowered from ten micrograms of lead to 3.5 micrograms.

HF24 (Jordan) - Authority modified to ensure safe drinking water, drinking water revolving fund provisions modified, grant program established to replace lead drinking water service lines, grant program established for mapping lead service lines, report required, and money appropriated.

HF347 (Howard) - Lead testing and remediation requirements in schools modified, report required, and money appropriated.

HFXXXX (Jordan) - State definition of lead service line, non-lead service line, galvanized service line, and galvanized service line in need of replacement.

HFXXXX (Jordan) - Modifying renovation and lead hazard reduction provisions.

Bills may be added or removed at the discretion of the chair.

PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows, and written testimony is encouraged.

To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
Bills Added:
HF24 (Jordan) - Lead drinking water service line replacement grant program established, report required, and money appropriated.
HF92 (Jordan) - Elevated blood lead concentration level lowered from ten micrograms of lead to 3.5 micrograms.
HF347 (Howard) - Lead testing and remediation requirements in schools modified, report required, and money appropriated.
Attachments:

Health Finance and Policy

1/31/2023
HF293 (Elkins): Medical and dental practices required to make available to the public their current standard charges, and commissioner of health authorized to establish a price comparison tool for items and services offered by medical and dental practices.

HF294 (Elkins): Manufacturers required to report and maintain prescription drug prices, filing of health plan prescription drug formularies required, health care coverage provisions modified, prescription benefit tool requirements established, and prescription drug benefit transparency and disclosure required.

HF926 (Elkins): Payments made to health care providers disclosure required, all-payer claims data provision changed, and transparency of health care payments report required.

Bills may be added or removed at the discretion of the chair.

AMENDMENTS: Deadline for amendments is 5:00PM, Monday, January 30, 2023.

PUBLIC TESTIMONY: If you would like to submit written testimony or sign up to testify, please contact the Committee Administrator at Josh.Sande@house.mn.gov. Testifiers must contact the Committee Administrator by 5pm the day prior to the hearing in order to sign up to testify in person. In person testimony may be limited as time allows, and written testimony is encouraged.

To learn more about requesting an accommodation, please visit the FAQs for Disability Access. If you have further questions on accommodations or accessibility, please contact the Committee Administrator.
Bills Added:
HF293 (Elkins) - Medical and dental practices required to make available to the public their current standard charges, and commissioner of health authorized to establish a price comparison tool for items and services offered by medical and dental practices.
HF294 (Elkins) - Manufacturers required to report and maintain prescription drug prices, filing of health plan prescription drug formularies required, health care coverage provisions modified, prescription benefit tool requirements established, and prescription drug benefit transparency and disclosure required.
HF926 (Elkins) - Payments made to health care providers disclosure required, self-insurer governing provision added, all-payer claims data provision changed, and transparency of health care payments report required.
Attachments:
H0294A2-1162106730250537746.pdf (1/27/2023)
H0926A1-12634486762228670843.pdf (1/30/2023)
AAM Letter - HF294 .pdf (1/30/2023)
Abraham_MNHouse_HF293_1302023.pdf (1/30/2023)
AHIP Comments on MN HF 294.pdf (1/30/2023)
CAE Comments on HF293 HF 294 and HF 926.pdf (1/30/2023)
EFMN Comments on HF 294.pdf (1/30/2023)
HF 294 __ Prescription Drug Benefit Transparency and Disclosure Required _ Frozen Formulary _ PCMA Testimony __ Michelle Mack __ House Health and Finance Policy _ FINAL.pdf (1/30/2023)
MAFP_Support HF 926.pdf (1/30/2023)
HF293 HRS.pdf (1/30/2023)
HF926 HRS.pdf (1/30/2023)
H0294A1-13846754184717982985.pdf (1/31/2023)
Health Finance & Policy Agenda 01.31.23.docx (1/31/2023)
TakingThePulse.pdf (1/31/2023)
PhRMA Statement - MN HF 294 Transparency & Price Control.pdf (1/31/2023)
Vertical-Integration-DCI-Oct2022.pdf (1/31/2023)
Supply Chain Slide.pdf (1/31/2023)
PPL_Updated Overview One-Pager[1].pdf (1/31/2023)
PBM-market-share-DCI-2021.pdf (1/31/2023)
More Than Half of Every Dollar Spent on Medicines Goes to Someone Who Doesnt Make Them 4ALT.pdf (1/31/2023)
Why Hospitals and Health Insurers Didn’t Want You to See Their Prices - The New York Times.pdf (1/31/2023)
What Does Knee Surgery Cost_ Few Know, and That’s a Problem - WSJ.pdf (1/31/2023)
Schafer_ We already knew hospital pricing was a mess, so now what_.pdf (1/31/2023)
Hospitals Hide Pricing Data From Search Results - WSJ.pdf (1/31/2023)
9-15-21-Hospital_Price_Transparency.pdf (1/31/2023)
HF58-2E (HF294) Evaluation Report.pdf (1/31/2023)
Milliman_Frozen Formulary Report_FINAL.pdf (1/31/2023)
HF294 HRS.pdf (1/31/2023)
HF 293 Elkins MNASCA MNOncology MSIPP.pdf (1/31/2023)
Page: Page Size: 5 Total Results: 57
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12

Select Criteria

Choose a session year below - all committee audio recordings for that year will be listed in the results column.
Select Year

Choose a committee below - this list is based on the chosen session year and will filter results to that specific committee.
Select Committee